Graybug Vision announces pipeline expansion – Tips & Results

Graybug Vision Inc. today announced a strategic update on its pipeline programs GB-102 in wet age-related macular degeneration (wet AMD), GB-401 in primary open-angle glaucoma (POAG), as well as its newly acquired assets in corneal disease (GB-501 ), inherited retinal disorders (GB-601), and geographic atrophy (GB-701). “We are very pleased to advance GB-102 into a … Read more

DAVIO study shows positive safety results for EYP-1901 in wet AMD – Tips & Results

Reviewed by Jay S. Duker, MD Positive safety results from the Phase 1 DAVIO clinical trial were obtained for the DuraSert implant (EYP-1901, Vorolanib, EyePoint Pharma), a bioerodible implant for previously treated wet age-related macular degeneration (AMD), according to Jay S. Duker, MD, Chief Operating Officer, who presented the 8-month results at the Angiogenesis, Exudation, … Read more

Focus on post-injection endophthalmitis – Tips & Results

Publisher’s Note: the times of ophthalmology® Research Scholar Honoree Program is dedicated to educating fellows and residents of the retina by providing a unique opportunity for fellows and residents to share remarkable research and challenging cases with their peers and mentors. The program is supported by an unrestricted grant from Regeneron Pharmaceuticals. special to Ophthalmology … Read more

Home monitoring patients for AMD: targeting CNV – Tips & Results

Reviewed by Marcus T. Altman, MD Home monitoring of patients can be even more valuable than originally anticipated. A recent study found that a large proportion of new-onset cases of age-related macular degeneration (AMD) were detected by home monitoring, and that the eyes monitored by the device were at the time choroidal neovascularization (CNV) was … Read more

Maintaining visual anatomical benefits with port delivery system in lengthening study – Tips & Results

Preliminary long-term safety and efficacy data for the Port Delivery System (PDS) with ranibizumab (Susvimo, Genentech) show that the device maintains visual and anatomical outcomes for 3 years and beyond. Additionally, patients with neovascular age-related macular degeneration (nAMD) prefer this treatment over monthly injections of anti-vascular endothelial growth factor drugs, according to David Eichenbaum, MD, … Read more

5 tips to block blue light in an increasingly remote world – Tips & Results

As consistent use of digital devices remains a fact of life for people of virtually any age, consider this expert advice With the continued nationwide spread of the virus that causes COVID-19, some traditionally in-person activities — work, school, and social interactions — are likely to be absent more frequently than usual for the foreseeable … Read more